Equity Mates Investing Podcast cover image

$100 million sign on bonuses, will Ren sell Novo Nordisk & how to find a great buyers agent?

Equity Mates Investing Podcast

00:00

Pharmaceutical Market Showdown

This chapter analyzes the competitive dynamics between Novo Nordisk and Eli Lilly in the realm of weight loss and diabetes medications, focusing on sales, production costs, and patent strategies. It forecasts the imminent impact of generics entering the market and emphasizes the need for innovation among branded companies to sustain profitability amid increased competition.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app